A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors
Clinical trial NCT06154343 · UNKNOWN
Trial details
- NCT number
- NCT06154343
- Sponsor
- GeneQuantum Healthcare (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2024-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.